Lenalidomide added to bendamustine-rituximab for untreated chronic lymphocytic leukemia (CLL): A phase 1 study.

被引：0
|
作者：
Abramson, Jeremy S.
Davids, Matthew Steven
Werner, Lillian
Fisher, David Christopher
Armand, Philippe
Amrein, Philip C.
Neuberg, Donna S.
Hochberg, Ephraim P.
Brown, Jennifer R.
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7082
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemia
    Soumerai, Jacob D.
    Davids, Matthew S.
    Werner, Lillian
    Fisher, David C.
    Armand, Philippe
    Amrein, Philip C.
    Neuberg, Donna
    Hochberg, Ephraim P.
    Brown, Jennifer R.
    Abramson, Jeremy S.
    LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 2931 - 2938
  • [2] A phase II study of lenalidomide in previously untreated, symptomatic chronic lymphocytic leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Mariela, Pantoja
    Brandwein, Joseph
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Tong, Jieffei
    Moran, Mike
    BLOOD, 2007, 110 (11) : 608A - 608A
  • [3] Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia
    Maurer, Christian
    Pflug, Natali
    Bahlo, Jasmin
    Kluth, Sandra
    Rhein, Christina
    Cramer, Paula
    Gross-Ophoff, Carolin
    Langerbeins, Petra
    Fink, Anna-Maria
    Eichhorst, Barbara
    Kreuzer, Karl-Anton
    Fischer, Norbert
    Tausch, Eugen
    Stilgenbauer, Stephan
    Boettcher, Sebastian
    Doehner, Hartmut
    Kneba, Michael
    Dreyling, Martin
    Binder, Mascha
    Hallek, Michael
    Wendtner, Clemens-Martin
    Bergmann, Manuela
    Fischer, Kirsten
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (03) : 253 - 260
  • [4] Bendamustine in Combination with Rituximab for Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients: An Italian Retrospective Multicentre Study
    Gentile, Massimo
    Ciolli, Stefania
    Molica, Stefano
    Di Renzo, Nicola
    Selleri, Carmine
    Villa, Maria Rosaria
    De Paolis, Maria Rosaria
    Scortechini, Ilaria
    Giannotta, Angela
    Minoia, Carla
    Rago, Angela
    Boncompagni, Riccardo
    Bonanno, Vincenza
    Levato, Luciano
    Musso, Maurizio
    Mastrullo, Lucia
    Melpignano, Angela
    Murru, Roberta
    Angelucci, Emanuele
    Tarantini, Giuseppe
    Caparrotti, Giuseppe
    Guarini, Attilio
    Ferrara, Felicetto
    Cimino, Giuseppe
    Zinzani, Pier Luigi
    Morabito, Fortunato
    BLOOD, 2014, 124 (21)
  • [5] Preliminary Results From a Phase I/II Study of Fludarabine, Rituximab, and Lenalidomide In Untreated Patients with Chronic Lymphocytic Leukemia (CLL)
    Flinn, Ian W.
    Berdeja, Jesus G.
    Waselenko, Jamie K.
    Cooper, R. Seth
    Bi, Jia
    Shih, Kent
    Doss, Habib H.
    Dickson, Natalie
    Thompson, Dana S.
    Burris, Howard A., III
    Hainsworth, John D.
    BLOOD, 2010, 116 (21) : 1022 - 1022
  • [6] A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Snitzler, Susi
    Kakar, Sumeet
    Le, Lisa W.
    Wei, Ellen N.
    Lau, Anthea
    Johnston, James B.
    Gibson, Spencer B.
    Queau, Michelle
    Spaner, David
    Croucher, Danielle
    Sherry, Barbara
    Trudel, Suzanne
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 980 - 989
  • [7] Bendamustine plus rituximab in untreated chronic lymphocytic leukemia patients. The MDA-CLL-2015-02 study
    De La Fuente, Adolfo
    Navas, Begona
    Gutierrez, Antonio
    Jose Terol, Maria
    Callejas, Marta
    Garcia Marco, Jose Antonio
    Dolores Garcia-Malo, Maria
    de la Serna, Javier
    Teresa Gonzalez-Gascon y Marin, Isabel
    Sanchis, Laura Garcia
    Ballesteros, Monia
    Benavente, Celina
    Jarque, Isidro
    Ochoa Gullon, Juliana
    Beneit, Paola
    de Ona, Raquel
    Montalabn, Carlos
    Estevez, Monica
    Iglesias, Rebeca
    Diaz-Lopez, Antonio
    Baltasar, Patricia
    LEUKEMIA & LYMPHOMA, 2017, 58 : 200 - 201
  • [8] A Phase II Stud of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine
    Paul, Harminder
    Xu, Wei
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Li, Zhi Hua
    Brandwein, Joseph
    Pantoja, Mariela
    Leung-Hagensteijn, Chungyee
    BLOOD, 2008, 112 (11) : 23 - 23
  • [9] Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440)
    Stilgenbauer, Stephan
    Morschhauser, Franck
    Wendtner, Clemens-Martin
    Cartron, Guillaume
    Hallek, Michael
    Eichhorst, Barbara
    Kozloff, Mark F.
    Giever, Thomas
    Lozanski, Gerard
    Jiang, Yanwen
    Huang, Huang
    Pignataro, Daniela Soriano
    Schary, William
    Humphrey, Kathryn
    Mobasher, Mehrdad
    Salles, Gilles
    HAEMATOLOGICA, 2021, 106 (11) : 2834 - 2844
  • [10] Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
    Fischer, Kirsten
    Cramer, Paula
    Busch, Raymonde
    Boettcher, Sebastian
    Bahlo, Jasmin
    Schubert, Joeerg
    Pflueger, Karl H.
    Schott, Silke
    Goede, Valentin
    Isfort, Susanne
    von Tresckow, Julia
    Fink, Anna-Maria
    Buehler, Andreas
    Winkler, Dirk
    Kreuzer, Karl-Anton
    Staib, Peter
    Ritgen, Matthias
    Kneba, Michael
    Doehner, Hartmut
    Eichhorst, Barbara F.
    Hallek, Michael
    Stilgenbauer, Stephan
    Wendtner, Clemens-Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3209 - 3216
12345